Core Insights - Universal Health Services Inc. reported second-quarter adjusted earnings of $5.35 per share, exceeding the consensus estimate of $4.92 [1] - The company generated sales of $4.28 billion, reflecting a year-over-year increase of 9.6%, surpassing the consensus estimate of $4.24 billion [1] Acute Care Hospitals - Adjusted admissions at acute care hospitals increased by 2.0%, while adjusted patient days rose by 1.1% year over year [2] - Net revenue per adjusted admission increased by 3.8%, and net revenue per adjusted patient day increased by 4.7% [2] - Net revenues from acute care services increased by 7.9% on a same facility basis [3] Behavioral Health Care Facilities - Adjusted admissions at behavioral health care facilities increased by 0.4%, and adjusted patient days increased by 1.2% [4] - Net revenue per adjusted admission rose by 8.6%, while net revenue per adjusted patient day increased by 7.8% [4] - Net revenues from behavioral health care services increased by 8.9% on a same facility basis [4] Company Operations - Universal Health operates 29 inpatient acute care hospitals and 338 inpatient behavioral health facilities, along with 61 outpatient facilities [5] Guidance - The company raised its fiscal year 2025 adjusted earnings guidance to $20.00-$21.00 per share, compared to the previous range of $18.45-$19.95 [6] - Sales guidance for 2025 was narrowed to $17.09 billion-$17.31 billion, against the previous range of $17.02 billion-$17.36 billion [6] - The forecasted adjusted EBITDA for 2025 was revised to approximately $2.46 billion-$2.543 billion, up from the prior range of $2.36 billion-$2.48 billion [6] Analyst Insights - Guggenheim Partners noted that adjusted EBITDA-NCI of $643 million exceeded the consensus estimate of $615 million, but core performance was weaker than expected due to adjustments [7] - Analyst Jason Cassorla indicated that higher 2025 EBITDA could lead to increased share repurchase, with a leverage ratio of 1.9x providing flexibility for returns [8] - Despite a recent ~15% drop in stock price, UHS is trading at historically low valuation levels, with cautious investor sentiment regarding future growth in the behavioral health segment [9]

Market Trends & Trade Developments - Trade developments are being taken in stride by the markets, with a focus shifting towards earnings, the Federal Reserve, and jobs reports [2][1] - Uncertainty remains a key characteristic of the market, but trade deals are progressing, earnings are strong, and consumer spending is holding up [3] - Overall earnings are broadening out, which is healthy for the marketplace [7] Investment Strategy & Opportunities - Investors need a strategy in an uncertain market [2][3] - Strategy should involve keeping cash and locking in higher rates before the Federal Reserve potentially lowers interest rates in the latter half of the year [4] - Healthcare sector has been lagging year-to-date, potentially representing a value play [6] - AMD is highlighted as a pick due to its upside potential in the AI trade [7][8] Company Performance & Analysis - UnitedHealth Group (UNH) reported earnings of $48 per share, which was $0.40 below estimates, with revenue slightly ahead of estimates at $1116 billion (111.6 * 10^9) [5] - Despite missing on EPS, UNH stock is moving higher, possibly indicating a bottoming in the healthcare sector [5][6] - AMD increased the pricing of its MI350 chip (rival to Nvidia's Blackwell) by 67%, from $15000 to $25000, indicating strength in the AI space [8][9]

We saw Europe weakness yesterday, a real feature once again today, down 2/10 of a percent on 1562 is where we train. I mean, this was a currency that had been at a three year high coming into this agreement. So what can we tell from this euro weakness.Right. Absolutely. I think the context is really important.It's seen as the biggest rally since the years since 2003. It's a really huge gain that we've seen in the euro. And look, that has been about dollar weakness.We've seen the same with the pounds as well ...

>> Thanks for watching. Fast money starts right now. >> Hey I'm Cramer, welcome to Mad Money. Welcome to Cramerica other my friends I'm just trying to make you a little money.My job is not just to entertain you but to educate and to teach you. So call me at one 800 703 CNBC or tweet me JimCramer. We've now got two trade deal wins on our hands.Last week's deal with Japan and this weekend's deal with the European Union. Despite the market's muted response Dow slipping 64 points S&P inching up 0.02% Nasdaq adv ...

Market Trends & Economic Factors - This week's events, including the Fed decision, PPE data, and jobs report, could be an inflection point for stocks trading near records [1] - Markets are pricing in potential weakness in the labor market, despite current strength [4] - Tariffs are now six times higher than when Trump took office, representing the highest levels in post-World War history, which could become an issue [3] - Confidence is returning, leading to increased spending, particularly in CapEx [15] Company Performance & Earnings - UPS stock has been a disaster for 3.5-4 years, cut in half, indicating company-specific problems [5] - Coinbase's upcoming report is crucial given its recent run; strong results are needed to justify valuation [6] - Tech earnings, particularly Google's, are in focus; while Google had a good quarter and guidance, CapEx spending is now viewed with caution [7][8] - Meta's spending on talent and CapEx, coupled with Llama 3's performance, raises concerns about profitability [9][10] - Microsoft's Azure is gaining traction in AI sales due to its OpenAI relationship [11] Bond Market & Yields - The bond market is stubborn, with yields starting to tick up, indicating a potential shift in market sentiment [6] - There will be a level where the market starts to care about bond yields [7]

And this week is critical for the stock market as investors get ready to digest a Fed decision, July jobs report, and earnings results from mag seven names Meta, Microsoft, Amazon, and Apple. Joining me now to highlight other earnings that should be on your radar this week is Victoria Green from G Squared Private Wealth. Uh Victoria, good to see you.So, what are some of the B sides that you think are worth listening to this week. The Bside. Oh man, it's so weird to talk about these companies as also rans.Lo ...

Financial Performance - Whirlpool's adjusted earnings per share (EPS) were $1.34, missing estimates of $1.74 [1] - Revenues reached $3.77 billion, falling short of the estimated $3.88 billion [1] - The company projects full-year revenue of $15.8 billion, exceeding estimates of $15.66 billion [1] - Full-year adjusted EPS is guided to $6 to $8, significantly below the $9.13 estimate [1] Market Dynamics & Tariffs - North American revenue amounted to $2.4 billion, slightly surpassing estimates [1] - Excluding currency effects, North American net sales decreased by 4.6% [1] - Competitors' stockpiling of Asian imports into the US impacted the second quarter [1] - Whirlpool believes evolving tariff policies will ultimately support domestic manufacturers [1] Stock Performance - Shares are down nearly 11% [1]

Core Insights - Park National Corporation reported a strong financial performance for the second quarter and first half of 2025, with significant increases in net income and earnings per share compared to the same periods in 2024 [2][15]. Financial Performance - Net income for Q2 2025 was $48.1 million, a 22.2% increase from $39.4 million in Q2 2024. Earnings per diluted common share rose to $2.97 from $2.42 in the same quarter last year [2][11]. - For the first half of 2025, net income reached $90.3 million, up 21.1% from $74.6 million in the first half of 2024, with earnings per diluted common share increasing to $5.56 from $4.60 [2][15]. Loan and Deposit Growth - Total loans increased by 1.9% (3.8% annualized) in the first half of 2025 and by 3.9% over the 12-month period ending June 30, 2025 [3]. - Reported period-end deposits rose by 1.2% (2.3% annualized) during the first half of 2025, although they decreased by 0.9% over the 12-month period [4]. Operational Efficiency - The company achieved a 21% increase in earnings per share through disciplined expense control and margin expansion [5]. - The net interest margin improved to 4.75% in Q2 2025, up from 4.39% in Q2 2024, reflecting effective management of interest income and expenses [12]. Asset Quality - Total nonperforming loans decreased by 9.9% year-over-year, indicating improved asset quality [13]. - The allowance for credit losses as a percentage of period-end loans was 1.13%, consistent with the previous year [14]. Market Data - The company declared a quarterly cash dividend of $1.07 per common share, payable on September 10, 2025 [1][19]. - As of June 30, 2025, Park National Corporation had total assets of $9.9 billion [5][21].

Market Overview & Expectations - S&P 500 rally is heavily influenced by the earnings of major tech companies, particularly the "Magnificent Seven" [1] - Investors are showing caution due to high valuations and expectations for these companies [4][5] - Earnings expectations for this group have slightly decreased to 16% quarter-over-quarter growth, down from 19% [6] Key Companies & Performance - Microsoft and Meta are significant drivers of the S&P 500 rally, especially since April [2][10] - Apple is down approximately 15% year-to-date, facing scrutiny regarding AI plans and China exposure [3] - Amazon's stock performance is relatively flat year-to-date [2] Earnings Impact & Strategy - Companies must "beat and raise" earnings to sustain the rally in their stocks [6] - Delivering strong results is crucial to justify the stretched valuations of these companies [7] - Positive earnings reports are being rewarded with share price increases, while negative reports are punished [11] Index Level Implications - Poor performance from key companies like Microsoft could lead to turmoil at the index level [10] - Apple's potential recovery could significantly boost the S&P 500 [8]

UnitedHealth Group Outlook - Street is trying to understand the next 6-18 months, with less focus on 2025 [2] - Expectation of reintroduced guidance from UnitedHealth with a new CEO [2] - Potential earnings range of $18-$20 for the balance of the year or fiscal year 2025 may be sufficient [3] - Previous expectations for UnitedHealth were closer to the high $20s, now trying to determine the trough earnings number [4] - Focus is on price discovery and investor multiple on future earnings (2026, 2027, etc) [4] Pharmaceutical Tariff Implications - Potential tariff angle on big pharma is being considered [1][5] - Street is bracing for a potential 15%-25% tariff rate across the board for large-cap pharma [7] - Sector-wide tariff has been rumored for 6-8 weeks with no concrete action [7] - Clarity on tariffs could lead to a rally in pharma stocks [8] - Uncertainty remains regarding the administration's actions and clarity on pharmaceutical policies [9] Pharmaceutical Industry Challenges - Focus on bringing pharmaceuticals back to America [6] - Potential impact of most favored nations status [9] - Losses of exclusivity are well-documented challenges [10]